To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06298266 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06298266
- Sponsor
- Guangdong Second Provincial General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2026-05-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.